欢迎访问ProbeChem中文网站，英文网站请访问www.probechem.com
    英文 |     中文

产品咨询: sales@probechem.com
订购: order@probechem.com

首页-小分子抑制剂&激动剂-Cell Cycle/DNA Damage-Cyclin-dependent Kinase (CDK)-YX0798
YX0798

Chemical Structure : YX0798

CAS No.:

加入收藏

YX0798 (YX-0798)

货号: PC-25129Not For Human Use, Lab Use Only.

YX0798 is a potent, selective and oral bioavailable CDK9 inhibitor with binding Kd of 0.28 nM, 16-50-fold more selective for CDK9 than CDK7, CDK3, or CDK4.

规格 价格 库存 数量
50 mg Get quote
100 mg Get quote
200 mg Get quote
获取报价单
* 请选择数量再加入购物车
 or Bulk Inquiry

大包装，大折扣！

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC)

生物&药学活性

YX0798 is a potent, selective and oral bioavailable CDK9 inhibitor with binding Kd of 0.28 nM, 16-50-fold more selective for CDK9 than CDK7, CDK3, or CDK4.
YX0798 binds to CDK9 in the ATP binding site.
YX0798 has a greater CDK9 affinity and selectivity than AZD4573.
YX0798 (IC50 = 25.2-109.9 nM) is highly potent in killing BTKi-sensitive MCL cells (Mino and JeKo 1) and BTKi-resistant cells (JeKo BTK KD and Z138), but not healthy PBMCs.
YX0798 potently inhibited cell viability and induced apoptosis in all MCL cell lines tested.
YX0798 inhibited CDK9 phosphorylation, induced poly-ADP ribose polymerase (PARP) and caspase 3 cleavage, and reduced anti-apoptotic MCL-1 in a dose-dependent manner in Z138 cells.
YX0798 also dose-dependently suppressed phosphorylation of CDK9 substrate RNA Pol II at Ser2, but not Ser5.
YX0798 effectively inhibits the growth of patient MCL cells in cell culture and patient-derived model, triggers cell cycle arrest at G0/G1 phase.
YX0798 not only depletes the expression of oncogenic c-MYC and pro-survival MCL-1 but also drives transcriptomic reprogramming towards cell cycle dysregulation and ROS production.

物理化学性质&存储条件

分子量 465.86
分子式 C21H19ClF3N5O2
外观性状 Solid
CAS No.
储存条件
固体粉末
-20°C 12 个月; 4°C 6 个月
配置液
-80°C 6 个月; -20°C 6 个月
Shipping
Solubility

10 mM in DMSO
Chemical Name/SMILES

(1S,3R)-N-(5-chloro-4-(1H-pyrrolo[2,3-b]pyridin-4-yl)pyridin-2-yl)-3-(2,2,2-trifluoroacetamido)cyclohexane-1-carboxamide

参考文献

1. Jiang V, et al. Blood Adv. 2025 Jul 21:bloodadvances.2025016511.

备案号：沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: